The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

@article{Arber2016The2R,
  title={The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.},
  author={D. Arber and A. Orazi and R. Hasserjian and J. Thiele and M. Borowitz and M. L. Le Beau and C. Bloomfield and M. Cazzola and J. Vardiman},
  journal={Blood},
  year={2016},
  volume={127 20},
  pages={
          2391-405
        }
}
  • D. Arber, A. Orazi, +6 authors J. Vardiman
  • Published 2016
  • Medicine
  • Blood
    • The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues was last updated in 2008. [...] Key Method The revisions to the categories of myeloid neoplasms and acute leukemia will be published in a monograph in 2016 and reflect a consensus of opinion of hematopathologists, hematologists, oncologists, and geneticists. The 2016 edition represents a revision of the prior classification rather than an entirely new classification and attempts to incorporate new clinical…Expand Abstract
    View PDF
    3,771 Citations
    Highly Influential Citations
    342
    Background Citations
    1,284
    Methods Citations
    562
    Results Citations
    36

    Supplemental Presentations

    Presentation Slides
    The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
    Explore Further
    Discover more papers related to the topics discussed in this paper

    Paper Mentions

    Interventional Clinical Trial
    Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients
    This study assesses the potential of using a TGFβ receptor inhibitor for the treatment of anemic patients with myeloproliferetive neoplasms. TGFβ signaling is known to be abnormally… Expand
    ConditionsMyeloproliferative Neoplasm
    InterventionDrug
    Weill Medical College of Cornell University
    September 2019 - September 2023
    Observational Clinical Trial
    Prognostic Value of CD318 in AML at Assiut University Hospital.
    We will focus on the prognostic value of CD318 in acute myeloid leukemia patients at Assiut University Hospital  
    ConditionsAcute Myeloid Leukemia
    InterventionDiagnostic Test
    Assiut University
    March 2021 - March 2023
    Observational Clinical Trial
    Immunophenotyping and Xist Gene in AML
    Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by clonal expansion of myeloid progenitors (blasts) in the bone marrow and peripheral blood.Several studies have… Expand
    ConditionsAcute Myeloid Leukemia
    InterventionDiagnostic Test, Genetic
    Assiut University
    May 2020 - December 2022
    Interventional Clinical Trial
    High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)
    Myelodysplastic syndromes (MDS) are the most frequent myeloid neoplasms in Western Countries.They mainly affect patients aged 65 years or older. This is a very heterogenous group… Expand
    ConditionsHigh-risk Myelodysplastic Syndromes With Excess Blasts
    InterventionDiagnostic Test
    Central Hospital, Nancy, France
    October 2017 - January 2022
    3,771 Citations
    Citation Type

    Citation Type

    Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know
    Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias).
    • 1
    The 2016 WHO classification of acute myeloid leukemia: What the practicing clinician needs to know.
    • D. Arber
    • Medicine
    • Seminars in hematology
    • 2019
    • 15
    The 2016 revision to the World Health Organization classification of myelodysplastic syndromes
    • Ming Hong, G. He
    • Medicine
    • Journal of translational internal medicine
    • 2017
    • 22
    • PDF
    Diagnosis of Myeloproliferative Neoplasms: Current Perspectives from Recent Research
    Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    • J. Leonard, P. Martin, G. Roboz
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2017
    • 35
    Conventional cytogenetics for myeloid neoplasms in the era of next‐generation‐sequencing
    • 2
    An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL)
    • 14
    Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories.
    • 12
    • PDF
    Mixed-phenotype acute leukemia: state-of-the-art of the diagnosis, classification and treatment.
    • 5
    • PDF

    References

    SHOWING 1-10 OF 167 REFERENCES
    Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system.
    • 139
    • PDF
    Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
    • 88
    The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
    • 3,841
    • PDF
    Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management
    • 173
    Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification.
    • 89
    Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms
    • 34
    • PDF
    The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
    • 152
    • PDF
    Should myeloid and lymphoid neoplasms with PCM1‐JAK2 and other rearrangements of JAK2 be recognized as specific entities?
    • 46
    Revised international prognostic scoring system for myelodysplastic syndromes.
    • 1,646
    • PDF
    Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system.
    • 209
    • PDF